Angiosarcoma: A study of 98 cases with immunohistochemical evaluation of TLE3, a recently described marker of potential taxane responsiveness

Journal of Cutaneous Pathology

Volumn 38, Issue 12, 2011, Pages 961-966

  Shon, Wonwoo ^a   Jenkins, Sarah M ^a   Ross, Douglas T ^b   Seitz, Robert S ^b   Beck, Rodney A ^b   Ring, Brian Z ^b   Okuno, Scott H ^a   Gibson, Lawrence E ^a   Folpe, Andrew L ^a  

^a MAYO CLINIC   (United States)

^b Clarient Inc   (United States)

Author keywords

angiosarcoma; taxane; TLE3

Indexed keywords

ANTINEOPLASTIC AGENT; BRIDGED COMPOUND; COREPRESSOR PROTEIN; NUCLEAR PROTEIN; TAXANE; TAXOID; TLE3 PROTEIN, HUMAN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ANGIOSARCOMA; ARTICLE; BIOSYNTHESIS; CHILD; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SKIN TUMOR; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BRIDGED COMPOUNDS; CHILD; CHILD, PRESCHOOL; CO-REPRESSOR PROTEINS; DISEASE-FREE SURVIVAL; FEMALE; HEMANGIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; NUCLEAR PROTEINS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE; TAXOIDS; TUMOR MARKERS, BIOLOGICAL;

EID: 80755187847     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2011.01790.x     Document Type: Article

References (25)

1. Deyrup AT, Mckenney JK, Tighiouart M, et al., Sporadic cutaneous angiosarcomas: a proposal for risk stratification based on 69 cases. Am J Surg Pathol 2008; 32: 72.
2. Deyrup AT, Weiss SW., Grading of soft tissue sarcomas: the challenge of providing precise information in an imprecise world. Histopathology 2006; 48: 42.
3. Coindre JM, Trojani M, Contesso G, et al., Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986; 58: 306.
4. Costa J, Wesley RA, Glatstein E, Rosenberg SA., The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer 1984; 53: 530.
5. Penel N, Marreaud S, Robin YM, et al., Angiosarcoma: state of the art and perspectives. Crit Rev Oncol Hematol 2010. DOI: 10.1016/j.critrevonc.2010.10. 007.
6. Leon C, Lobe CG., Grg3, a murine Groucho-related gene, is expressed in the developing nervious system and in mesenchyme-induced epithelial structures. Dev Dyn 1997; 208: 11.
7. Liu Y, Dehni G, Purcell KJ, et al., Epithelial expression and chromosomal location of human TLE genes: implications for Notch signaling and neoplasia. Genomics 1996; 31: 58.
8. Kulkarni SA, Hicks DG, Watroba NL, et al., TLE3 as a candidate biomarker of response to taxane therapy. Breast Cancer Res 2009; 11: R17.
9. R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2008. ISBN 3-900051-07-0, URL http://www.R-project.org.
10. Holden CA, Spittle MF, Jones EW., Angiosarcoma of the face and scalp, prognosis and treatment. Cancer 1987; 59: 1046.
11. Meis-Kindblom JM, Kindblom LG., Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol 1998; 22: 683.
12. Billings SD, McKenney JK, Folpe AL, Hardacre MC, Weiss SW., Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. Am J Surg Pathol 2004; 28: 781.
13. Brenn T, Fletcher CD., Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases. Am J Surg Pathol 2005; 29: 983.
14. Fletcher CD, Unni KK, Mertens F., Pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press, 2002.
15. Lahat G, Dhuka AR, Lahat S, et al., Outcome of locally recurrent and metastatic angiosarcoma. Ann Surg Oncol 2009; 16: 2502.
16. Eriksson M., Histology-driven chemotherapy of soft-tissue sarcoma. Ann Oncol 2010; 21 (Suppl. 7): vii270.
17. Penel N, Bui BN, Bay JO, et al., Phase II trial of weekly paclitaxel for unresectable angiosarcomas: the ANGIOTAX study. J Clin Oncol 2008; 26: 5269.
18. Belotti D, Vergani V, Drudis T, et al., The microtubules-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 1996; 2: 1843.
19. Abbott R, Palmieri C., Angiosarcoma of the breast following surgery and radiotherapy for breast cancer. Nat Clin Pract Oncol 2008; 5: 727.
20. Campone M, Levy V, Bourbouloux E, et al., Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours. Br J Cancer 2009; 100: 315.
21. Gambini D, Visintin R, Locatelli E, et al., Paclitaxel-dependent prolonged and persistent complete remission four years from first recurrence of secondary breast angiosarcoma. Tumori 2009; 95: 828.
22. Murray S, Simmons I, James C., Cutaneous angiosarcoma of the face and scalp presenting as alopecia. Australas J Dermatol 2003; 44: 273.
23. Nagano T, Yamada Y, Ikeda T, Kanki H, Kamo T, Nishigori C., Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients. Cancer 2007; 110: 648.
24. Sher T, Hennessy BT, Valero V, et al., Primary angiosarcomas of the breast. Cancer 2007; 110: 173.
25. Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ., Angiosarcoma. Lancet Oncol 2010; 11: 983.